NLRP3 and neoplasm: Alpinumisoflavone, an anticancer drug for the treatment of HCC, could effectively induce cancer cell pyroptosis through NLRP3 inflammasome‐dependent pathway to increase the expression of pyroptosis‐related genes for enhanced tumor inhibition.271